Breast cancer drug may save 1,000 lives a year
· First proof of improved five-year survival rate· Treatment is aimed at post-menopausal women
Herceptin will work wonders, not miracles
Gavyn Davies: The revolutionary drug Herceptin was this week licensed by the European Commission to fight early-stage breast cancer, and it now seems probable that it will shortly be cleared for clinical use in the UK.
Breast cancer study finds fewer doses of radiotherapy effective
· More intense treatment, less often, could result· Patients spared anxiety of daily hospital visits
Which is the quack medicine?
Richard Smith: Quite a lot of orthodox treatments are unsupported by firm evidence.
NHS go-ahead for new breast cancer drugs
· Aromatase inhibitors for use alongside tamoxifen · Treatment costs 10 times more than at present